Fifth Third Bancorp’s Juno Therapeutics, Inc. JUNO Stock Holding History

Fifth Third Bancorp’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-500	Closed	-$23K	–	2485
2017 Q4	$23K	Hold	500	–	–	﹤0.01%	1563
2017 Q3	$22K	Hold	500	–	–	﹤0.01%	1568
2017 Q2	$15K	Hold	500	–	–	﹤0.01%	1635
2017 Q1	$11K	Sell	500 -1,579	-76%	-$33.9K	﹤0.01%	1713
2016 Q4	$39K	Sell	2,079 -1	-0%	-$24	﹤0.01%	1419
2016 Q3	$62K	Buy	+2,080	New	+$64.7K	﹤0.01%	1252
2016 Q1	–	Sell	-338	Closed	-$15K	–	2848
2015 Q4	$15K	Buy	338 +153	+83%	+$7.59K	﹤0.01%	1810
2015 Q3	$8K	Buy	+185	New	+$8.11K	﹤0.01%	2135

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Fifth Third Bancorp's JUNO Position: Q1 2018 in Review

Fifth Third Bancorp sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 500 shares — an estimated $23K sold.

Fifth Third Bancorp first reported a position in JUNO in Q3 2015 and held it in 8 quarters. The position peaked at $62K in Q3 2016. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Fifth Third Bancorp reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Fifth Third Bancorp sold 500 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $23K.
Fifth Third Bancorp first reported a position in Juno Therapeutics, Inc. in Q3 2015 and held it in 8 quarters.
Fifth Third Bancorp's Juno Therapeutics, Inc. position peaked at $62K in Q3 2016.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Fifth Third Bancorp's 13F filing for Q1 2018, filed 15 May 2018.